Clinical categories of Langerhans cell histiocytosis (LCH) include single and multi-system disease. Pulmonary LCH is rare, which is an unusual interstitial lung disease with the characteristics of monoclonal proliferation and infiltration of Langerhans cells to organs. We report our experience of a rare LCH case of multiple organs such as pulmonary and liver as the main clinical manifestation. The patient was treated with chemotherapy which included prednisone, vinblastine, methotrexate and 6-mercaptopurine for 52 weeks and follow up all along. The patient has a favorable clinical outcome. Chin Med J 2012;125(9):1675-1676
第一作者机构：[1]Capital Med Univ, Beijing Childrens Hosp Affiliated, Hematol Ctr, Beijing 100045, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Childrens Hosp Affiliated, Hematol Ctr, Beijing 100045, Peoples R China
推荐引用方式(GB/T 7714)：
Ma Xiao-li,Shen Kun-ling,Wang Bin.A child with pulmonary and liver Langerhans'-cell histiocytosis[J].CHINESE MEDICAL JOURNAL.2012,125(9):1675-1676.doi:10.3760/cma.j.issn.0366-6999.2012.09.031.
APA：
Ma Xiao-li,Shen Kun-ling&Wang Bin.(2012).A child with pulmonary and liver Langerhans'-cell histiocytosis.CHINESE MEDICAL JOURNAL,125,(9)
MLA：
Ma Xiao-li,et al."A child with pulmonary and liver Langerhans'-cell histiocytosis".CHINESE MEDICAL JOURNAL 125..9(2012):1675-1676
